Back to BlackRock, Inc. BlackRock, Inc.

PLXPLX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in PROTALIX BIOTHERAPEUTICS INC

BlackRock, Inc. holds 4M shares of PLX (PROTALIX BIOTHERAPEUTICS INC), worth $9.4M as of 2026-Q2. The position was increased (+11.9% shares). PLX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$9.4M

Current Shares

4M

Total Value Change

+$9M

Total Shares Change

+3.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4M
+11.9%
$9.4M0.0%$2.33
31
2026-Q1
Decreased
3.6M
-0.8%
$7.8M0.0%$2.83
0
2025-Q4
Increased
3.6M
+2.7%
$6.6M0.0%$1.74
28
2025-Q3
Increased
3.6M
+5.4%
$7.9M0.0%$2.16
29
2025-Q2
Increased
3.4M
+1223.8%
$5M0.0%$1.54
43
2025-Q1
Increased
254,535
+13.3%
$651,6100.0%$2.58
19
2024-Q4
First report
224,657
-
$422,3540.0%$1.89
0

Other major holders of PLX: BlackRock Finance, Inc., RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used